Abstract
Bruxism is a disorder that affects people of all ages, especially young adults, and can be classified as sleep bruxism and awake bruxism. This involuntary condition involves grinding or clenching the teeth, resulting in problems such as orofacial pain, dental wear, and sleep disorders, impacting the quality of life of those affected. With the increasing prevalence of bruxism, it is essential to find effective treatments. This study explored botulinum toxin (BT) as a therapeutic alternative for bruxism, evaluating its effectiveness in reducing symptoms and comparing it with other treatment modalities. The results of the study indicated the effectiveness of using the toxin for the therapeutic management of bruxism, with the purpose of reducing the symptoms caused by this parafunction. It was concluded from the reviewed articles that this substance can bring relief to the problem, relieving tension and its symptoms.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
